Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 65.20
-1.00 (-1.51%)
Jul 6, 2026, 3:59 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 3.15 billion as of July 6, 2026. Its market cap has increased by 72.46% in one year.
Market Cap
3.15B
Enterprise Value
7.43B
Revenue
9.96B
Ranking
n/a
PE Ratio
16.25
Stock Price
65.20
Market Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 3.15B, a decrease of -7.34%. That is a compound annual growth rate of -0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 3.15B | 26.83% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 165.87B |
| Sectra AB | 56.99B |
| Getinge AB | 55.78B |
| Medicover AB | 36.02B |
| Vicore Pharma Holding AB | 3.66B |
| Hansa Biopharma AB | 3.55B |
| CellaVision AB | 3.49B |
| Egetis Therapeutics AB | 3.00B |